Palisade Bio Inc (PALI) concluded trading on Wednesday at a closing price of $1.05, with 10.19 million shares of worth about $10.7 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -70.67% during that period and on March 12, 2025 the price saw a gain of about 11.70%. Currently the company’s common shares owned by public are about 2.77M shares, out of which, 2.74M shares are available for trading.
Stock saw a price change of 27.50% in past 5 days and over the past one month there was a price change of -9.48%. Year-to-date (YTD), PALI shares are showing a performance of -36.36% which decreased to -81.87% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.75 but also hit the highest price of $9.65 during that period. The average intraday trading volume for Palisade Bio Inc shares is 1.61 million. The stock is currently trading 14.80% above its 20-day simple moving average (SMA20), while that difference is down -20.37% for SMA50 and it goes to -64.52% lower than SMA200.
Palisade Bio Inc (NASDAQ: PALI) currently have 2.77M outstanding shares and institutions hold larger chunk of about 7.20% of that.
The stock has a current market capitalization of $2.90M and its 3Y-monthly beta is at 1.32. It has posted earnings per share of -$15.04 in the same period. It has Quick Ratio of 3.28 while making debt-to-equity ratio of 0.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PALI, volatility over the week remained 13.93% while standing at 9.52% over the month.
Stock’s fiscal year EPS is expected to rise by 56.80% while it is estimated to increase by 74.99% in next year. EPS is likely to shrink at an annualized rate of 52.91% for next 5-years, compared to annual growth of 75.28% made by the stock over the past 5-years.